Form 4: Vertex Pharmaceuticals EVP and CMO, Carmen Bozic, Reports Stock Disposal
SEC Form 4 Filing
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals, reported the disposal of 3,310 shares of common stock to cover tax obligations.
Summary
- On February 24, 2025, Carmen Bozic, the Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals, disposed of 3,310 shares of common stock.
- The transaction was executed at a price of $483.28 per share.
- Following the transaction, Bozic directly owns 37,631 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a stock disposal, likely for tax purposes, which is a routine transaction.
Industry Context
Form 4 filings are a routine part of insider trading activity and are closely watched by investors for signals about management's confidence in the company's prospects. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of stock disposal transaction |
| 02/26/2025 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.